Dr. Sandra Vranic

NanoCell Biology Team Leader



Sandra obtained her BSc Degree in Molecular Biology and Physiology at the University of Belgrade, Serbia in 2007. After graduation she completed her MRes Degree in Toxicology at University Paris Diderot – Paris 7, France. She pursued her PhD in Toxicology in the Laboratory of Molecular and Cellular Responses to Xenobiotics at University Paris Diderot – Paris 7, supervised by Prof Armelle Baeza and Dr Sonja Boland. She focused on interactions of manufactured engineered nanoparticles with cells, especially on the mechanisms of their internalization and subsequent cellular effects.

After her PhD, Sandra obtained Japanese Society for Promotion of Science (JSPS) Postdoctoral Fellowship at Nagoya University and Tokyo University of Science in Japan supervised by Professor Gaku Ichihara, where she focused on the effects of silica nanoparticles on mice and zebrafish models. She joined the Nanomedicine Lab in January 2015 as a Marie Curie Research Fellow under the RADDEL ITN project studying carbon-based nanocapsules filled with radiometals aimed for biomedical applications in the areas of cancer diagnosis and therapy.

Sandra is a lead scientist in the Graphene Flagship WP4 Health & Safety and 2D-Health projects, and the PI of EU-funded Horizon 2020 project BIORIMA. In November 2018 she was appointed as Lecturer in Nano-Cell Biology. Her team aims to investigate the cellular and molecular biology mechanisms and pathways on interaction of 2D and other nanomaterials using tissue organoid models and contribute to the discovery of new therapeutic modalities.